75906-36-4

Basic information

• Product Name: Benzenebutanol, 4-bromo-
• Synonyms: Benzenebutanol, 4-bromo-;4-(4-Bromo-phenyl)-butan-1-ol;4-Bromo-benzenebutanol
• CAS NO: 75906-36-4
• Molecular Formula: C₁₀H₁₃BrO
• Molecular Weight: 229.11362
• Mol File: 75906-36-4.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzenebutanol, 4-bromo-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenebutanol, 4-bromo-(75906-36-4)
• EPA Substance Registry System: Benzenebutanol, 4-bromo-(75906-36-4)

Safety Data

• Hazardous Substances Data: 75906-36-4(Hazardous Substances Data)

Usage

General Description

Benzenebutanol, 4-bromo- is a chemical compound with the molecular formula C10H13BrO. It is a clear, colorless liquid with a faint, sweet odor. This chemical is used as a solvent in various industries, as well as a reagent in organic synthesis. It is also commonly used as a precursor in the production of other organic compounds. Benzenebutanol, 4-bromo- is known to have some potential health hazards, and proper safety precautions should be taken when handling and using this chemical.

Upstream product

• 35656-89-4 4-(4-bromophenyl)butanoic acid 
• 59099-79-5 4-(4-bromophenyl)-3-butyn-1-ol 
• 589-87-7 1,4-bromoiodobenzene 
• 1122-91-4 4-bromo-benzaldehyde 
• 22135-53-1 1-(4'-bromophenyl)-1-butanol 
• 74532-94-8 1-bromo-4-(but-1-en-1-yl)benzene 

Downstream Products

• 943750-38-7 2-(4-bromo-phenyl)-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 194725-15-0 rac-2-(4-bromophenyl)tetrahydrofuran 

Relevant articles and documents

GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE

The present invention discloses a glycoside compound represented by Formula III, and a preparation method, a composition, use and an intermediate thereof. The glycoside compound provided in the present invention has simple preparation method, can significantly increase the expression of VEGF-A mRNA, and is effective in promoting the angiogenesis. This provides a reliable guarantee for the development of drugs with pro-angiogenic activity for treating cerebral infarction cerebral stroke, myocardial infarction, and ischemic microcirculatory disturbance of lower limbs.

Access to Trisubstituted Fluoroalkenes by Ruthenium-Catalyzed Cross-Metathesis

Although the olefin metathesis reaction is a well-known and powerful strategy to get alkenes, this reaction remained highly challenging with fluororalkenes, especially the Cross-Metathesis (CM) process. Our thought was to find an easy accessible, convenient, reactive and post-functionalizable source of fluoroalkene, that we found as the methyl 2-fluoroacrylate. We reported herein the efficient ruthenium-catalyzed CM reaction of various terminal and internal alkenes with methyl 2-fluoroacrylate giving access, for the first time, to trisubstituted fluoroalkenes stereoselectively. Unprecedent TON for CM involving fluoroalkene, up to 175, have been obtained and the reaction proved to be tolerant and effective with a large range of olefin partners giving fair to high yields in metathesis products. (Figure presented.).

GLUCOPYRANOSYL DERIVATIVE AND USE THEREOF

The present invention relates to a glucopyranosyl derivative and a use thereof. In particular, the present invention relates to a glucopyranosyl derivative that is used as an inhibitor of sodium-dependent glucose transporters (SGLTs), particularly being used as an inhibitor of sodium-dependent glucose transporter-1 (SGLT1), and a pharmaceutically acceptable salt or stereoisomer thereof, further relating to a pharmaceutical composition containing the derivative. The present invention further relates to a use of the compound and a pharmaceutical composition thereof in the preparation of a drug for treating diabetes and diabetes-related diseases.